Both in Pharmaceuticals
Nkarta vs Yarrow Bioscience
Over the past year NKTX returned −38.1% and YARW returned −32.2%; their daily moves had a correlation of 0.04.
NKTX −38.1% YARW −32.2%Growth of $1, one year, split-adjusted
| Metric | NKTX | YARW |
|---|---|---|
| Price | $1.80 | $18.31 |
| Market cap | $128.9M | $154.5M |
| Today | −6.74% | −8.45% |
| 1 month | −35.9% | −40.1% |
| 6 months | −48.1% | — |
| Year to date | −2.7% | — |
| 1 year | −31.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $182.8M | — |
| Dividend yield | — | — |
| Volatility (60d) | 61.4% | — |
| Short % of float | 8.7% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).